FDA Inspection 1169330 — Baxter Healthcare Corporation

Baxter Healthcare Corporation — FEI 1025114

The FDA completed an inspection of Baxter Healthcare Corporation on May 12, 2022 in Marion, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 7 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 12, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Marion, NC (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
122021 CFR 211.67(b)(3)Cleaning SOPs/instructions
136121 CFR 211.100(a)Absence of Written Procedures
195621 CFR 211.180(e)(1)Representative Number of Batches for Annual Review
200921 CFR 211.188Prepared for each batch, include complete information
430621 CFR 211.80(a)Written Procedures Not Followed

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.